|
|
Xueliang Du, Diane Edelstein, Silvana Obici, Ninon Higham, Ming-Hui Zou,, Michael Brownlee
J Clin Invest. 2006;
116(4):1071
doi:10.1172/JCI23354
Abstract |
Full text
| PDF

I
nsulin resistance markedly increases cardiovascular disease risk in people with normal glucose tolerance, even after adjustment for known risk factors such as LDL, triglycerides, HDL, and systolic blood pressure. In this report, we show that increased oxidation of FFAs in aortic endothelial cells without added insulin causes increased production of superoxide by the mitochondrial electron transport chain. FFA-induced overproduction of superoxide activated a variety of proinflammatory signals previously implicated in hyperglycemia-induced vascular damage and inactivated 2 important antiatherogenic enzymes, prostacyclin synthase and eNOS. In 2 nondiabetic rodent models — insulin-resistant, obese Zucker (fa/fa) rats and high-fat diet–induced insulin-resistant mice — inactivation of prostacyclin synthase and eNOS was prevented by inhibition of FFA release from adipose tissue; by inhibition of the rate-limiting enzyme for fatty acid oxidation in mitochondria, carnitine palmitoyltransferase I; and by reduction of superoxide levels. These studies identify what we believe to be a novel mechanism contributing to the accelerated atherogenesis and increased cardiovascular disease risk occurring in people with insulin resistance.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(49)
| Title and authors |
Publication |
Year |
The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update
Hanrui Zhang, Kevin C. Dellsperger, Cuihua Zhang
|
Basic Res Cardiol
|
2012 |
Hyperbaric oxygen therapy as treatment of diabetic foot ulcers : HBO as Treatment of Diabetic Foot Ulcers
Magnus Löndahl
|
Diabetes Metab. Res. Rev.
|
2012 |
FoxOs Integrate Pleiotropic Actions of Insulin in Vascular Endothelium to Protect Mice from Atherosclerosis
Kyoichiro Tsuchiya, Jun Tanaka, Yu Shuiqing, Carrie L. Welch, Ronald A. DePinho, Ira Tabas, Alan R. Tall, Ira J. Goldberg, Domenico Accili
|
Cell Metabolism
|
2012 |
Carnitine Palmitoyltransferase (CPT) Modulators: A Medicinal Chemistry Perspective on 35 Years of Research
Simona M. Ceccarelli, Odile Chomienne, Marcel Gubler, Arduino Arduini
|
J. Med. Chem.
|
2011 |
Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action
Hemant Poudyal, Sunil K. Panchal, Vishal Diwan, Lindsay Brown
|
Progress in Lipid Research
|
2011 |
MicroRNAs mediate metabolic stresses and angiogenesis
Francesca Patella, Giuseppe Rainaldi
|
Cell. Mol. Life Sci.
|
2011 |
Hyperbaric Oxygen: Its Mechanisms and Efficacy
Stephen R. Thom
|
Plastic and Reconstructive Surgery
|
2011 |
Preserved insulin vasorelaxation and up-regulation of the Akt/eNOS pathway in coronary arteries from insulin resistant obese Zucker rats
Cristina Contreras, Ana Sánchez, Albino García-Sacristán, M. Carmen Martínez, Ramaroson Andriantsitohaina, Dolores Prieto
|
Atherosclerosis
|
2011 |
Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta
Hua Li, Hongliang Li, Yige Bao, Xiangxun Zhang, Yerong Yu
|
International Journal of Cardiology
|
2011 |
High glucose impairs EDHF-mediated dilation of coronary arterioles via reduced cytochrome P450 activity
Shu-Huai Tsai, Travis W. Hein, Lih Kuo, Vivian C. Yang
|
Microvascular Research
|
2011 |
|